Statin Intolerance
Cardiologists discuss managing statin intolerance in clinical practice, highlighting the importance of creating individualized plans and when to initiate nonstatin therapies.
Source: hcplive.com
📰 Statin Intolerance News
Statin Intolerance News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Statin Intolerance. Real-time updates on events, politics, business and more.
Bempedoic Acid Proves Cardiovascular Benefit Across Glycemic Spectrum in New Analysis
A prespecified analysis of the CLEAR Outcomes trial assessing outcomes according to glycemic status suggests bempedoic acid provided similar relative benefits across the glycemic spectrum, but the greatest absolute benefits were observed in patients with diabetes.
Source: hcplive.com
Payer Considerations and Documentation Requirements for Treatment Prior Authorization Requests
A medical expert discusses preauthorization requests and requirements for cardiovascular disease treatment, commenting on an abstract presented at the ACC 2023 Annual Scientific Session and Expo and World Congress of Cardiology.
United States Erin Michos Pcsk9 Inhibitor Pcsk9 Monoclonal Antibodies Standarized Form Fda Approved Indication
Source: ajmc.com
Ask the Doctor: Statin intolerance, when to see a doctor, back acne
Dr. Bob Cassady from the South Bend Clinic joins us every Tuesday on 16 News Now at Noon to answer your medical questions.
Source: wndu.com
Non-Statin Therapies for Patients at High Risk for Cardiovascular Disease
Erin Michos, MD, MHS, opens a discussion surrounding the utilization of bempedoic acid for patients with intolerance to statin-based therapies.
Erin Michos Johns Hopkins University School Of Medicine World Congress Im Dr Erin Johns Hopkins University School Post Conference Perspectives
Source: ajmc.com
Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes
(UPDATED) The FDA required a CV outcomes trial to show the already-approved drug reduced the risk of MACE. The results are in.
Source: tctmd.com
Meta-Analysis Shows Prevalence of Statin Intolerance Is Low
WEDNESDAY, Feb. 16, 2022 (HealthDay News) -- The prevalence of statin intolerance (SI) is low, according to a meta-analysis published online Feb. 15 in the European Heart Journal.
National Lipid Association European Atherosclerosis Society International Lipid Expert Panel Healthday News European Heart Physicians Briefing
Source: hazard-herald.com
Modified Snacks Reduce LDL Cholesterol
A randomized crossover study using snacks with a particular constellation of nutrients including fiber, antioxidants, and phytosterols reduced LDL compared with snacks with similar calories.
United States Rush University Medical Center Kenneth Feingold Kim Allan Williams Stepheni Kopecky Arnold Miller
Source: medscape.com